Archon Biosciences, a biotech startup co-founded by Nobel Prize winner David Baker, focuses on computational protein design to enhance biologic drugs through innovative "antibody cages." Launched with $20 million in seed funding, the company aims to improve antibody properties while minimizing changes to their structure. With plans for clinical trials and a financial runway into 2026, Archon is poised to make significant advancements in drug development.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
